XEN1701, a Phase 2-Ready NaV1.7 Inhibitor: Advancing a Novel Non-Opioid Strategy for Pain
XEN1701, a Phase 2-Ready NaV1.7 Inhibitor: Advancing a Novel Non-Opioid Strategy for Pain
October 29, 2026
Congress: International Association for the Study of Pain (IASP) 2026 World Congress on Pain (October 29, 2026)
Authors: Gilbert, JP, et al